Hyderabad, India
AUROBINDO PHARMA LTD is a prominent player in the global pharmaceutical landscape, recognized for its commitment to innovation, quality, and accessibility as encapsulated in its slogan, "Committed to healthier life!" Established in 1986 and headquartered in India, the company has firmly rooted itself in the Biotechnology and Pharmaceutical industries.
Boasting a status as the largest generic pharmaceutical company in the United States and ranking among the top 10 in eight European nations, Aurobindo Pharma offers an extensive range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) in over 150 countries. Its robust therapeutic portfolio covers eight major areas, including Central Nervous System, Cardiovascular, and Oncology, backed by cutting-edge manufacturing facilities approved by global authorities such as the USFDA and UK MHRA.
While Aurobindo Pharma has not disclosed recent investments, its strong R&D infrastructure remains a core driver of its market leadership, focusing on leveraging innovation to enhance global health outcomes.
